4-(Pyridin-2-yl)-N'-(3,4,5-trimethoxybenzylidene)piperazine-1-carbohydrazide

ID: ALA4800161

PubChem CID: 162676580

Max Phase: Preclinical

Molecular Formula: C20H25N5O4

Molecular Weight: 399.45

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc(/C=N/NC(=O)N2CCN(c3ccccn3)CC2)cc(OC)c1OC

Standard InChI:  InChI=1S/C20H25N5O4/c1-27-16-12-15(13-17(28-2)19(16)29-3)14-22-23-20(26)25-10-8-24(9-11-25)18-6-4-5-7-21-18/h4-7,12-14H,8-11H2,1-3H3,(H,23,26)/b22-14+

Standard InChI Key:  ZPJWCVJWFWNSQI-HYARGMPZSA-N

Molfile:  

 
     RDKit          2D

 29 31  0  0  0  0  0  0  0  0999 V2000
   10.8903  -13.5249    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8892  -14.3444    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5972  -14.7534    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.3069  -14.3440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3041  -13.5213    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5954  -13.1160    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1847  -14.7502    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.4775  -14.3389    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7716  -14.7434    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7667  -15.5609    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.4739  -15.9723    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1860  -15.5661    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0571  -15.9663    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3513  -15.5545    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.0534  -16.7835    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.6417  -15.9598    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.9359  -15.5480    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2263  -15.9534    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5230  -15.5384    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8139  -15.9430    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8097  -16.7611    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5205  -17.1728    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2267  -16.7657    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1083  -15.5309    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.1124  -14.7137    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1007  -17.1674    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.3943  -16.7565    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5197  -17.9900    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.8115  -18.3978    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  7  8  1  0
  7 12  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
  2  7  1  0
 10 13  1  0
 13 14  1  0
 13 15  2  0
 14 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 18  1  0
 20 24  1  0
 24 25  1  0
 21 26  1  0
 26 27  1  0
 22 28  1  0
 28 29  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4800161

    ---

Associated Targets(Human)

BCHE Tclin Cholinesterases; ACHE & BCHE (1222 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BACE1 Tchem Beta-secretase 1 (15641 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BCHE Tclin Butyrylcholinesterase (7174 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ACHE Tclin Acetylcholinesterase (18204 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 399.45Molecular Weight (Monoisotopic): 399.1907AlogP: 1.97#Rotatable Bonds: 6
Polar Surface Area: 88.52Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 11.78CX Basic pKa: 6.42CX LogP: 1.86CX LogD: 1.82
Aromatic Rings: 2Heavy Atoms: 29QED Weighted: 0.59Np Likeness Score: -1.63

References

1. Tripathi A,Choubey PK,Sharma P,Seth A,Tripathi PN,Tripathi MK,Prajapati SK,Krishnamurthy S,Shrivastava SK.  (2019)  Design and development of molecular hybrids of 2-pyridylpiperazine and 5-phenyl-1,3,4-oxadiazoles as potential multifunctional agents to treat Alzheimer's disease.,  183  [PMID:31561043] [10.1016/j.ejmech.2019.111707]

Source